Annual Operating Expenses
$26.11 M
+$2.95 M+12.73%
December 31, 2023
Summary
- As of February 8, 2025, CLDI annual total operating expenses is $26.11 million, with the most recent change of +$2.95 million (+12.73%) on December 31, 2023.
- During the last 3 years, CLDI annual operating expenses has risen by +$19.33 million (+285.46%).
- CLDI annual operating expenses is now at all-time high.
Performance
CLDI Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$5.23 M
-$365.00 K-6.53%
September 30, 2024
Summary
- As of February 8, 2025, CLDI quarterly total operating expenses is $5.23 million, with the most recent change of -$365.00 thousand (-6.53%) on September 30, 2024.
- Over the past year, CLDI quarterly operating expenses has dropped by -$1.30 million (-19.94%).
- CLDI quarterly operating expenses is now -43.25% below its all-time high of $9.21 million, reached on December 31, 2023.
Performance
CLDI Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
CLDI Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.7% | -19.9% |
| 3 y3 years | +285.5% | -19.9% |
| 5 y5 years | +285.5% | -19.9% |
CLDI Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +140.9% | -43.3% | +57.4% |
| 5 y | 5-year | at high | +285.5% | -43.3% | +57.4% |
| alltime | all time | at high | +285.5% | -43.3% | +57.4% |
Calidi Biotherapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.23 M(-6.5%) |
| Jun 2024 | - | $5.59 M(-17.2%) |
| Mar 2024 | - | $6.75 M(-26.7%) |
| Dec 2023 | $26.11 M | $9.21 M(+41.1%) |
| Sep 2023 | - | $6.53 M(+15.6%) |
| Jun 2023 | - | $5.65 M(+19.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $4.72 M(+0.7%) |
| Dec 2022 | $23.16 M(+113.7%) | - |
| Dec 2022 | - | $4.69 M(-32.9%) |
| Sep 2022 | - | $6.99 M(+110.4%) |
| Dec 2021 | $10.84 M(+60.0%) | $3.32 M |
| Dec 2020 | $6.77 M | - |
FAQ
- What is Calidi Biotherapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Calidi Biotherapeutics?
- What is Calidi Biotherapeutics annual operating expenses year-on-year change?
- What is Calidi Biotherapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Calidi Biotherapeutics?
- What is Calidi Biotherapeutics quarterly operating expenses year-on-year change?
What is Calidi Biotherapeutics annual total operating expenses?
The current annual operating expenses of CLDI is $26.11 M
What is the all time high annual operating expenses for Calidi Biotherapeutics?
Calidi Biotherapeutics all-time high annual total operating expenses is $26.11 M
What is Calidi Biotherapeutics annual operating expenses year-on-year change?
Over the past year, CLDI annual total operating expenses has changed by +$2.95 M (+12.73%)
What is Calidi Biotherapeutics quarterly total operating expenses?
The current quarterly operating expenses of CLDI is $5.23 M
What is the all time high quarterly operating expenses for Calidi Biotherapeutics?
Calidi Biotherapeutics all-time high quarterly total operating expenses is $9.21 M
What is Calidi Biotherapeutics quarterly operating expenses year-on-year change?
Over the past year, CLDI quarterly total operating expenses has changed by -$1.30 M (-19.94%)